Motley Rice
Recent News About Motley Rice View More
-
Expert says Huntington/Cabell need more sufficient, longstanding treatment programs
CHARLESTON – Testifying in the bellwether opioid trial, a expert witness on pharmaceutical-related abatement programs said he does not believe Cabell County has sufficient treatment programs to fight the opioid epidemic. -
Child welfare expert discusses needs for Opioid Use Disorder exposed children
CHARLESTON – At the federal trial against three major opioid distributors, a child welfare expert showed the impact of Opioid Use Disorder on children and the rising need – and lack – of proper resources. -
Data shows Cabell County had some of nation’s top opioid prescribers
CHARLESTON – Tension remained high in the courtroom of the landmark federal opioid trial as plaintiffs and defendants argued expert witness reports and testimonies. -
Defense blames doctor’s overprescribing, tries to discredit expert witness report
CHARLESTON – As the landmark federal opioid trial entered its sixth week, tensions rose as defendants spent the day trying to discredit a report by a substance use disorder epidemiologist. -
Overdose data shows growing trends of opioid-related drug poisonings
CHARLESTON – An expert epidemiologist who analyzed Cabell County and West Virginia overdose data to show opioid trends in death rates soared from 2001 to 2017. -
Rannazzisi's testimony repeatedly challenged, questioned and stifled
CHARLESTON – A key former Drug Enforcement Administration official spent the day on the witness stand giving testimony between objections, legal limitations and frustrations. -
Rannazzisi testimony tries to shift blame away from DEA
CHARLESTON – A key former Drug Enforcement Administration officials took the stand in the landmark federal opioid trial, opening his testimony by saying drug distribution centers were well-equipped to prevent diversion. -
Drug companies grill addiction science director about funding numbers, program timelines
CHARLESTON – As the landmark federal opioid trial concluded its fourth week, attorneys for Cardinal Health probed an addiction science professor from Marshall University about recovery programs and estimated costs. -
Cabell sheriff paints picture of opioid crisis through testimony
CHARLESTON – At the landmark federal opioid trial, Cabell County Sherriff Chuck Zerkle testified being directly involved in Huntington, once deemed “epicenter of the opioid crisis,” has evolved. -
Drug distributors object to expert witness with DEA background looking at company data
CHARLESTON – All three major drug distribution companies objected to Cabell County and Huntington attorneys bringing in an expert witness with a U.S. Drug Enforcement Administration background to examine opioid data. -
McKesson warned customers nearing threshold limits
CHARLESTON – Attorneys representing Cabell County and the City of Huntington probed a McKesson sales representative on warning customers of nearing threshold limits, pushing increases and pushing sales – including controlled substances. -
Emails show McKesson employees felt 'overwhelmed,' 'not possible to be truly diligent'
CHARLESTON – As the landmark federal opioid trial entered its fourth week, plaintiffs jumped into McKesson Corporation’s threshold guidelines and due diligence process. -
Lawyers continue to question company's knowledge of excessive opioid shipments
CHARLESTON – As the landmark opioid trial continues, lawyers brought in a former AmerisourceBergen’s sales executive to ask what he knew about more than 32 million prescription pain pills being shipped to Huntington and the rest of Cabell County over an eight-year span. -
Opioid data: Threshold kept increasing as Huntington/Cabell received more than 36.2M doses in 8 years
CHARLESTON – As the federal trial against three major opioid distributors continued, data showing pharmacies in Huntington and Cabell County were ordering well above the national average of controlled substances, some ordering more than five times the national average. -
During testimony, official says Cabell Co. has data linking painkillers to illegal drug use
Meanwhile, the drug distributors -- McKesson, AmerisourceBergen and Cardinal Health -- sought to put the focus on the role of prescribers, as well as health officials' decision not to go after distributors earlier. -
Distributors object to Gupta's testimony on transition from prescription to street drugs
CHARLESTON – A historian of opioid use and drug policy testified, in a federal trial against three major opioid distributors Wednesday, about three principal opioid epidemics that preceded the ongoing crisis. -
Expert says brains have similar changes with prescription and illicit opioids
CHARLESTON -- While opioid distributors have argued there is no proof of connection between prescription painkiller use and illicit drug use, an expert in the neurobiology of addiction said, during the second day of a landmark federal trial against those distributors, that people who take prescription painkillers and illicit opioids see the same changes in their brain chemistry. -
UPDATE: Landmark federal opioid trial against three drug distributors begins
CHARLESTON – The landmark bellwether trial accusing three major drug distributors of helping fuel the opioid epidemic has begun. -
UPDATE: Federal judge denies more motions from opioid manufacturers as trial start looms
CHARLESTON – As the trial date looms next week, a federal judge again has denied motions for summary judgment from the defendant opioid distributors. -
Top opioid plaintiff lawyers plead for Walmart case to join action in Ohio
CLEVELAND (Legal Newsline) - The lawyers in charge of lawsuits against opioid manufacturers and distributors pleaded for a Walmart case against the government to be pulled into the court coordinating federal multidistrict litigation, saying the legal questions it raises have already been answered by judge overseeing the MDL.